Answers are grounded in this paper and cite their sources.
Novel platinum(IV)–texaphyrin conjugates were designed and synthesized in order to target cancer cells preferentially and to deliver platinum. Protected from light, these compounds are inert in aqueous environments and do not interact with DNA. However, following exposure to ambient light, a reduced, active PtII species, namely cisplatin, is released and binds to DNA. As a result, potent anti-proliferative activity in ovarian cancer cell lines is observed for the PtIV–texaphyrin conjugates. For more details see the Full Paper by J. L. Sessler et al. on page 8942 ff.
No takes yet. Share an insight, caveat, or question.
Thiabaud et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: